Results 131 to 140 of about 546 (157)
Some of the next articles are maybe not open access.

A closer inspection of tedizolid – Authors' reply

The Lancet Infectious Diseases, 2015
Philippe, Prokocimer   +3 more
openaire   +2 more sources

Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects

The Journal of Clinical Pharmacology, 2017
Shawn, Flanagan   +4 more
openaire   +2 more sources

Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity

International Journal of Molecular Sciences, 2021
Magdalena Paczkowska   +2 more
exaly  

Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success

Open Forum Infectious Diseases, 2022
Taylor Morrisette   +2 more
exaly  

Tedizolid Phosphate

Stephanie J. Phelps   +2 more
openaire   +2 more sources

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?

Journal of Antimicrobial Chemotherapy, 2020
Mike M Ruth   +2 more
exaly  

Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA

Pharmaceutical Research, 2022
Sho Tashiro   +2 more
exaly  

Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic

Clinical Infectious Diseases, 2015
Steven D Burdette, Burdette Steven D
exaly  

Home - About - Disclaimer - Privacy